Research ArticleArticle
Characterization of fasiglifam-related liver toxicity in dogs
Akifumi Kogame, Yuu Moriya, Ikuo Mori, Liping Pan, Akio Morohashi, Takuya Ebihara, Hideo Fukui, Yoshihiko Tagawa and Leslie Z. Benet
Drug Metabolism and Disposition February 14, 2019, dmd.118.084889; DOI: https://doi.org/10.1124/dmd.118.084889
Akifumi Kogame
1 Axcelead Drug Discovery Partners, Inc.;
Yuu Moriya
2 Takeda Pharmaceutical Company Limited;
Ikuo Mori
2 Takeda Pharmaceutical Company Limited;
Liping Pan
2 Takeda Pharmaceutical Company Limited;
Akio Morohashi
3 Nemoto Science. Co., Ltd.;
Takuya Ebihara
1 Axcelead Drug Discovery Partners, Inc.;
Hideo Fukui
1 Axcelead Drug Discovery Partners, Inc.;
Yoshihiko Tagawa
1 Axcelead Drug Discovery Partners, Inc.;
Leslie Z. Benet
4 University of California - San Francisco
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleArticle
Characterization of fasiglifam-related liver toxicity in dogs
Akifumi Kogame, Yuu Moriya, Ikuo Mori, Liping Pan, Akio Morohashi, Takuya Ebihara, Hideo Fukui, Yoshihiko Tagawa and Leslie Z. Benet
Drug Metabolism and Disposition February 14, 2019, dmd.118.084889; DOI: https://doi.org/10.1124/dmd.118.084889
Research ArticleArticle
Characterization of fasiglifam-related liver toxicity in dogs
Akifumi Kogame, Yuu Moriya, Ikuo Mori, Liping Pan, Akio Morohashi, Takuya Ebihara, Hideo Fukui, Yoshihiko Tagawa and Leslie Z. Benet
Drug Metabolism and Disposition February 14, 2019, dmd.118.084889; DOI: https://doi.org/10.1124/dmd.118.084889
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement